Uveitis is a leading cause of acquired blindness in children. The most common cause of chronic anterior uveitis in children is that associated with juvenile idiopathic arthritis. Though no therapeutics are approved for juvenile uveitis, novel biologic treatments may prove effective. Outcomes measures to evaluate therapeutics are being adapted and validated for children. A better understanding of the requirements for screening children with juvenile idiopathic arthritis for the presence of uveitis as well evidence for treatment options will aid adult and pediatric rheumatologists in preventing long-term ocular sequelae in children with juvenile idiopathic arthritis.
Upon completion of this session, participants should be able to:
- recognize the signs and symptoms of uveitis and assess for underlying disease
- identify the requirements for ocular screening for uveitis of children with juvenile idiopathic arthritis
- cite the evidence for recommendations for acute and chronic medical management for uveitis
- discuss the current state of development for outcomes measures for childhood uveitis
To see other sessions for this day, use the date buttons to the left.